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Abstract
Background: Semaphorins are known to play an important role in axon guidance and growth by
triggering dynamic rearrangements of the actin cytoskeleton in the neuronal growth cone.
Intriguingly, some of these guidance molecules are persistently expressed after axonal pathfinding
and target recognition are completed. Although their function at these later stages is poorly
understood, recent findings suggest a role for these proteins in regulating synaptic connections.
Results: Here we demonstrate that semaphorin 5B (Sema5B) regulates the elimination of synaptic
connections in cultured hippocampal neurons. We show that Sema5B is proteolytically processed
in neonatal brains and primary hippocampal cultures, resulting in the secretion of Sema5B
fragments that include the biologically active semaphorin domain. Overexpression of full-length
Sema5B in hippocampal neurons reduces synapse number while expression of a Sema5B construct
lacking the semaphorin domain has no effect. Moreover, bath application with the proteolytically
processed, secreted fragments containing the semaphorin domain of Sema5B, results in a rapid
elimination of synaptic connections as demonstrated by time-lapse imaging. Conversely, depletion
of endogenous Sema5B using RNA interference results in a significant increase in synapse number
as well as a significant increase in the size of presynaptic and postsynaptic compartments.
Conclusion: Our results demonstrate that in addition to its role as a guidance cue, Sema5B
regulates the development and maintenance of synapse size and number in hippocampal neurons.
In addition, proteolytic cleavage of Sema5B results in the release of a potentially diffusible
semaphorin domain that is a necessary component for its biological function in the regulation of
synapse morphology.
Background
The formation of synaptic connections between growing
axons and their appropriate targets is essential for proper
functioning of the nervous system. During development,
synaptic networks are refined through the elimination of
excessive or inappropriate synapses that have initially
been formed [1-3]. In addition to these early refinement
events, the assembly and disassembly of synapses persists
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into adulthood [4]. It has been suggested that this contin-
uous modification of synaptic connections may serve as a
cellular substrate for learning and memory [5,6] however
the molecular mechanisms regulating synapse formation
and elimination remain largely unknown.
The semaphorins are a large family of guidance molecules
that are involved in processes such as cell migration,
axonal guidance, and axonal fasciculation [7]. While the
majority of semaphorins act as inhibitory or repellent
molecules, some semaphorins also function as permissive
or attractive cues [8-10]. Semaphorins typically confer
their inhibitory activity through a conserved 500 amino
acid 'sema' domain [9], while a variety of alternative func-
tions are associated with their varied C-terminal domains.
Several members of the semaphorin family have recently
been shown to affect the structure and function of central
nervous system (CNS) synapses. The invertebrate trans-
membrane protein, Sema1A, is required for the formation
of the giant fiber synapse in Drosophila melanogaster, but
overexpression of this protein results in synaptic destabi-
lization [11]. In mammals, bath application of the
secreted semaphorins, Sema3A and Sema3F, decreases
and increases, respectively, synaptic transmission in cul-
tured hippocampal neurons [12,13]. Signaling through
the Sema3F receptor plexin A3 is also necessary for the
elimination of inappropriate synaptic contacts between
dentate gyrus mossy fibers and cornu ammonis (CA)3
pyramidal cells during normal hippocampal develop-
ment [14].
The semaphorin Sema5B is expressed in a variety of
regions in the developing brain including the hippocam-
pus [15-17]. Its persistent expression at postnatal stages
suggests that Sema5B may contribute to the functioning
of neuronal circuits and specifically to the regulation of
synaptic functions. Sema5B is a transmembrane protein
that, in addition to the typically inhibitory sema domain,
possess seven thrombospondin repeats [15,16]. This is
intriguing as thrombospondins are permissive for axon
outgrowth and enhance synaptogenesis, suggesting a
bifunctional role for Sema5B [15,18]. Indeed, the Sema5B
homologue, Sema5A, has previously been shown to func-
tion as a permissive or inhibitory cue to axon outgrowth
depending on local matrix proteoglycans [19]. Whether
Sema5B may have similar bifunctional characteristics is
unknown.
Here, we provide evidence that Sema5B is involved in syn-
apse elimination in hippocampal neurons. Overexpres-
sion of green fluorescent protein (GFP)-Sema5B in
hippocampal neurons results in a decrease in synapse
number, however this effect is eliminated when the repul-
sive sema domain is removed. Accordingly, bath applica-
tion of hippocampal neurons with secreted Sema5B
fragments containing the sema domain resulted in the
elimination of postsynaptic, postsynaptic density (PSD)-
95 clusters. Conversely, depletion of endogenous Sema5B
using short hairpin RNA (shRNA) resulted in the exuber-
ant formation and/or maintenance of synaptic connec-
tions, with a concomitant increase in the size of pre and
postsynaptic densities. These data therefore reveal a new
role for semaphorins in regulating synapse maintenance
and morphology and provide insights into the role that
these guidance molecules may play in the developing
brain.
Results
Sema5B antibody
Antibodies were generated against the N-terminus of full
length Sema5B (anti-5B) along a region that showed the
least amino acid homology with other semaphorins
including Sema5A (Figure 1a). This antibody recognized a
hemaglutinin (HA)-tagged recombinant form of Sema5B
at approximately 150 kDa (Figure 1b) but did not crossre-
act with a purified Sema5A (Figure 1c). In contrast, a 150
kDa Sema5B band was absent in postnatal day 1 (P1) cor-
tical or hippocampal lysates, but several smaller bands
were apparent indicating that the majority of Sema5B is
proteolytically processed (Figure 1d). Similar bands were
observed in 21 days in vitro (DIV) and freshly cultured
hippocampal neurons (Figure 1d). The anti-5B antibody
recognized a number of bands, all 110 KDa and smaller,
indicating that the sema domain is proteolytically cleaved
from the full length Sema5B and could potentially act as
a diffusible molecule. As further validation of the specifi-
city of the anti-5B antibody, the N-terminal peptide frag-
ment was able to compete with the endogenous Sema5B
epitopes (see Figure 2, [Additional file 1]), and there was
a reduction of Sema5B immunolabeling in Sema5B knock
down cells [Additional file 2].
Sema5B is expressed in the developing and adult 
hippocampus
Previous  in situ hybridization data has shown robust
Sema5B mRNA expression in the developing rodent brain
that is also maintained in the postnatal hippocampus
[15,17]. To confirm this expression, postnatal day 1 (P1)
and adult brain sections were immunolabeled for Sema5B
(Figure 2a–i). Sema5B was robustly expressed in the CA1-
CA3 pyramidal cell layer as well as the dentate gyrus in
both neonatal and adult mice (Figure 2a–i). Sema5B was
also localized to the stratum radiatum region immediately
adjacent to the pyramidal cell layer. This reflected Sema5B
localization in the neurites of CA1-CA3 cells, as well as
Sema5B expression in interneurons (Figure 2b, d, g).
Immunostaining in the stratum radiatum region appeared
more robust in P1 mice compared to adults. This may
reflect the dynamic nature of synapse formation and elim-Neural Development 2009, 4:18 http://www.neuraldevelopment.com/content/4/1/18
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ination at earlier versus later stages. Preadsorption with
the peptide used in the generation of the Sema5B anti-
body resulted in reduced immunocytochemical labeling
confirming the specificity of this antibody (Figure 2b, c;
[Additional file 1]).
The specificity of the 5B antibody was also demonstrated
by immunolabeling hippocampal neurons transfected
with full-length Sema5B fused to GFP (GFP-Sema5B).
Indeed, Sema5B levels were markedly higher in GFP-
Sema5B-expresing cells compared to surrounding,
untransfected neurons, which expressed endogenous
Sema5B (Figure 3a–c). In untransfected cells, Sema5B
exhibited a punctate distribution in the cell body and
colocalized with both MAP-2 (Figure 3d–f) and tau (Fig-
ure 3g–i) indicating its localization in both dendrites and
axons, respectively. Immunolabeling with the inhibitory
marker glutamate decarboxylase (GAD)-65 revealed that
both GAD-65-positive and GAD-65-negative cells express
Sema5B. This indicates that Sema5B is expressed by both
inhibitory and excitatory cells (Figure 3j–l). As the punc-
tate distribution along the neurites was suggestive of a
synaptic distribution, cells were also labeled with anti-
bodies against the excitatory postsynaptic marker, PSD-95
(Figure 3m–o) and the presynaptic marker, synapto-
physin (data not shown). There did not appear to be an
enrichment of Sema5B at synaptic compartments
although there was some minimal colocalization
observed between Sema5B and PSD-95 (Figure 3o, inset).
Finally, Sema5B expression was also observed in glial
fibrillary acidic protein (GFAP)-positive glial cells (Figure
3p–q).
Sema5B antibody specificity Figure 1
Sema5B antibody specificity. (a) Schematic illustration of Sema5B including the region in the N-terminus used to generate 
the antibody. The amino acids bordering the sema domain and thrombospondin repeats are indicated. (b) Lysates from human 
embryonic kidney (HEK)293 cells transfected with hemaglutinin (HA)-Sema5B were separated by SDS-PAGE and immunoblots 
probed with antibodies specific to Sema5B or HA. Antibodies recognize a predominant band at approximately 150 kDa corre-
sponding to HA-Sema5B. (c) Anti-5B does not recognize a full-length mouse Sema5A extracellular domain Fc-human fusion 
protein (Sema5A-Fc). Purified Sema5A-Fc and Fc proteins (kindly provided by Dr D Sretavan) were separated by SDS-PAGE 
and immunoblots probed with antibodies specific to Sema5B (anti-5B) or anti-human Fc chain (anti-Fc). Some crossreactivity 
was observed in the Fc lane, most likely between the anti-rabbit IgG secondary and the large amount of human Fc loaded on 
the gel. Sema5A-Fc ran at the expected molecular weight of ~170 Kda. (d) Sema5B is proteolytically processed in vivo. Lysates 
from P1 mouse brains and hippocampal neurons cultured for 0 and 21 days in vitro (DIV) were separated by SDS-PAGE and 
immunoblots probed with anti-5B. Numerous repeatable bands were observed indicating proteolytic processing of Sema5B in 
the nervous system. N = 4 brains.
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Overexpression of GFP-Sema5B decreases synapse 
number
To investigate the function of Sema5B at synapses, GFP-
Sema5B was expressed in cultured hippocampal neurons
(Figure 4). Immunolabeling with GFP antibodies of non-
permeabilized human embryonic kidney (HEK)293 cells
expressing GFP-Sema5B showed that it was appropriately
targeted to the cell membrane (data not shown). To exam-
ine the effects of GFP-Sema5B overexpression on syn-
apses, neurons were cotransfected with the excitatory
postsynaptic marker PSD-95 fused to red fluorescent pro-
tein (RFP) to visualize postsynaptic densities. Cultures
were then fixed and immunolabeled for synaptophysin,
and synapses identified by the colocalization of the pre
and postsynaptic markers synaptophysin and PSD-95-
RFP, respectively (Figure 4b, e, h). Although the number
of PSD-95-RFP puncta were similar between control and
Sema5B overexpressing cells (311.5 ± 30.4; 266.1 ± 35.84,
respectively, P = 0.33), the percentage of PSD-95 puncta
that have an associated synaptophysin puncta, and the
density of PSD-95/synaptophysin puncta was signifi-
cantly lower in GFP-Sema5B expressing cells compared to
control cells (Figure 4j). This indicated that the number of
synaptic inputs from wild type neurons onto the Sema5B
Sema5B is expressed in the hippocampus Figure 2
Sema5B is expressed in the hippocampus. (a-i) Immunolabeling of coronal brain sections demonstrating Sema5B expres-
sion in cornu ammonis (CA)1-CA3 hippocampal pyramidal neurons and in the dentate gyrus. Preadsorption with the peptide 
used in the generation of the Sema5B antibody resulted in reduced immunocytochemical labeling, confirming the specificity of 
this antibody (b, c). Sema5B was localized along the length of the neurites ((b, d), arrows) and in a subset of cells in the stratum 
radiatum ((d), arrowhead). (a-i) N = 4 brains. Scale bar; (a) 200 μm, (b-i) 40 μm.Neural Development 2009, 4:18 http://www.neuraldevelopment.com/content/4/1/18
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overexpressing cell was significantly attenuated (see
model, Figure 5).
To determine the number of synapses being made by the
Sema5B overexpressing cells onto wild type neurons, cells
were cotransfected with GFP-Sema5B and the presynaptic
marker synaptophysin-RFP and then immunolabeled for
PSD-95. The number of synaptophysin puncta in control
and Sema5B-expressing cells was similar (201.2 ± 37.4;
180.1 ± 18.1, respectively) and no significant difference
was observed in the percentage of synaptophysin puncta
that have an associated PSD-95 puncta (Figure 4k). There-
fore, although overexpressed Sema5B is distributed to
both axons and dendrites, it is the increased expression in
dendrites that results in a reduction in synapse number
(see model, Figure 5).
The sema domain of Sema5B is required for the decrease 
in synapse number
The sema domain of semaphorins typically acts to medi-
ate the biological actions of these guidance molecules [9].
To determine whether this domain plays a role in regula-
tion of synapse elimination, hippocampal neurons were
transfected with Sema5B lacking the sema domain (GFP-
5BΔsema). Despite a robust expression of GFP-5BΔsema
throughout the neuron, we observed no effect on the den-
sity and proportion of PSD-95-RFP puncta that have an
associated synaptophysin puncta (Figure 4). This indi-
cates the semaphorin domain of Sema5B is largely
responsible for the reduction in synapse number follow-
ing Sema5B overexpression.
Treatment of hippocampal neurons with supernatant from 
HEK293 expressing Sema5B results in synapse elimination
Sema5B stimulates growth cone avoidance and collapse of young 
hippocampal neurons
Numerous semaphorins and their receptors are proteolyt-
ically processed, and in the case of Sema4D, the sema
domain is cleaved from the full-length protein resulting in
a secreted peptide [20-22]. Our data suggests that similar
processing of Sema5B occurs in the hippocampus (Figure
1d). To further verify that hippocampal neurons can
respond to Sema5B, neurons were cocultured with
HEK293 cells transiently transfected with HA-Sema5B or
a variety of truncated/deletion mutants. After 2 days in
culture hippocampal neurites were observed to avoid con-
tact with HEK293 cells expressing constructs that con-
tained the sema domain (Figure 6b, arrowheads), but
grew robustly over control, untransfected HEK293 cells
(Figure 6b, arrows). While the majority of neurites avoid
HEK293 cells expressing Sema5B, on occasion one or two
neurites will contact and cross transfected cells (Figure 6b;
see also [17]). Nonetheless, the high degree of avoidance
observed suggested that Sema5B is biologically active for
hippocampal neurons. The most robust repulsion was
observed when hippocampal neurons were cocultured
with HEK293 cells that expressed a form of Sema5B that
had the entire intracellular C-terminus removed (HA-
Sema5BΔC) (Figure 6b). Although the avoidance of
Sema5BΔC-expressing cells by hippocampal neurites
could be due to contact mediated repulsion, the collapse
of growth cones several microns away from the cells could
be due to a short diffusible signal (Figure 6b). To test this
possibility, hippocampal neurons were bathed with con-
centrated supernatant from HEK293 cells expressing HA-
Sema5BΔC. Bath application resulted in the collapse of
neurites in a dose-dependent manner (Figure 6d, e),
whereas supernatant from untransfected cells had no
impact on growth cone collapse (Figure 6c). These obser-
vations indicate that hippocampal neurons are responsive
to Sema5B and exhibit a collapsed/avoidance response
similar to that observed with dorsal root ganglion neu-
rons [23]. In addition, these data indicate that the collapse
and/or repulsion of processes are due to a biologically
active fragment of Sema5B that is released into the media
from the transfected HEK293 cells. To confirm the pres-
ence of a secreted form of Sema5B, the supernatant from
cells expressing HA-Sema5BΔC was concentrated, run on
an SDS-PAGE gel, and probed with an anti-HA antibody.
A number of bands were observed between 100 and 130
kDa with one prominent band at approximately 130 kDa
(Figure 6a). These N-terminal fragments are sufficiently
large enough to contain the entire semaphorin domain of
Sema5B. We were unable to concentrate soluble secreted
Sema5B expression in hippocampal neurons Figure 3 (see previous page)
Sema5B expression in hippocampal neurons. (a-r) Confocal images of 7 to 10 days in vitro (DIV) hippocampal cultures 
immunolabeled with anti-5B antibody plus the specified marker. (a-c) Immunolabeling of a hippocampal neuron transfected 
with green fluorescent protein (GFP)-Sema5B demonstrated that Sema5B levels were markedly higher in the GFP-Sema5B-
expresing cells (arrow) compared to the surrounding, untransfected neurons. (d-i) In untransfected cells, Sema5B was 
expressed in dendrites labeled with microtubule-associated protein 2 (MAP-2) (arrows, (d-f)) and axons labeled with tau 
(arrowheads; g-i). (j-l) Both glutamate decarboxylase (GAD)-65-positive (arrowhead) and GAD-65-negative (arrow) cells 
expressed Sema5B. (m-o) Coimmunolabeling with the postsynaptic marker, postsynaptic density (PSD)-95, demonstrated min-
imal colocalization (insert, arrows), demonstrating that Sema5B is not particularly enriched at synapses. (p-r) Sema5B expres-
sion was also observed in glial fibrillary acidic protein (GFAP)-positive glial cells. Scale bar; a-l 40 μm, m-o 20 μm and p-r 40 
μm.Neural Development 2009, 4:18 http://www.neuraldevelopment.com/content/4/1/18
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Figure 4 (see legend on next page)
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fragments from hippocampal culture supernatants despite
our observations that hippocampal tissue lysates showed
the presence of these fragments (Figure 1d). This may
reflect the low concentrations of secreted sema fragments
in hippocampal cultures.
Bath application with Sema5B results in synapse elimination in older 
hippocampal cultures
Based on the observation that overexpression of GFP-
Sema5B, but not GFP-5BΔsema, results in the reduction in
synapse number, we investigated whether the secreted
sema domain of Sema5B has an effect on the generation
and/or stability of synapses. To determine the effect of
supernatant treatment on synaptogenesis, 9 to 10 DIV
hippocampal cultures were treated with supernatant from
293 cells expressing HA-Sema5BΔC (Figure 7). Specifi-
cally, a quarter to a half of the concentration of superna-
tant that produced maximal growth cone collapse in the
collapse assay was used for bath application. After bath
application, a reduction in the number of synapses, iden-
tified by the colocalization of synaptophysin and PSD-95
puncta, was observed (Figure 7g–j). Increasing the super-
natant decreased the percentage of PSD-95 puncta that
had an associated Syn puncta twofold, from approxi-
mately 40% to 10% after 2 h (Figure 7c, f, i, j). This effect
did not appear to be secondary to collapse, as there were
few examples of neurite collapse observed despite the loss
of synaptic sites (see Figure 8). To confirm these observa-
tions, experiments were repeated using time-lapse imag-
ing. Neurons expressing GFP to visualize neurite
morphology and PSD-95-RFP to visualize postsynaptic
densities were treated with the supernatant of HA-
Sema5BΔC-transfected HEK293 cells and imaged every 10
minutes for 60 to 90 minutes following bath application.
At 1 h after treatment there was a 56% decrease in the
number of PSD-95-RFP puncta (Figure 8). In control cells,
only minimal fluctuations in the number of PSD-95
puncta were observed over time (Figure 8g). These fluctu-
ations may be attributed to biological changes in protein
localization over time, or slight drifts in focal planes.
Bleaching of fluorophores is unlikely as exposure times
were short, and laser intensity minimal. The reduction of
PSD-95 puncta in response to HA-Sema5BΔC bath appli-
cation was not secondary to decreased cell viability, as no
difference in survival was observed using the dye YO-
PRO-1 as an early apoptotic marker, or using the highly
sensitive colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) cell viability assay
(data not shown).
Sema5B protein knockdown increases synapse number 
and size
To further examine the role of Sema5B at the synapse,
Sema5B protein levels were attenuated using shRNAs.
One of the known caveats of shRNA is the 'off-target'
effects, where unintended transcripts are silenced [24]. To
minimize this possibility, two different shRNAs were used
to reduce Sema5B protein levels. Previous reports have
demonstrated a significant knockdown of Sema5B by
Sema5B shRNA1 and Sema5B shRNA3 in heterologous
cells and brain tissue [17]. We confirmed Sema5B knock-
down in primary hippocampal neurons using immunocy-
tochemistry (see [Additional file 2]). To determine the
effect of Sema5B knockdown on synapse number, neu-
rons were cotransfected with PSD-95-RFP and cultures
immunolabeled for synaptophysin (Figure 9). Expression
of both shRNA constructs resulted in a modest yet signifi-
cant increase in the number of synapses as identified by
PSD-95/synaptophysin colocalization (Figure 9b, d, e),
while the number of synapses in cells expressing control
scrambled shRNA were similar to that of wild type neu-
rons (Figure 9a, c, e). In addition, the size of PSD-95-RFP
puncta in Sema5B knockdown neurons (Figure 9c, d, f)
and synaptophysin puncta apposing Sema5B knockdown
neurons (Figure 9c, d, g) was significantly increased.
Increased clustering of PSD-95 has been shown to drive
synapse maturation by recruiting a number of PDZ
domain-containing proteins to postsynaptic sites, which
in turn results in an increased accumulation of synapto-
physin presynaptically and an increase in miniature exci-
tatory postsynaptic currents (mEPSCs) (PDZ is an
acronym combining the first letters of three proteins first
discovered to share the domain: PSD-95, Drosophila disc
Overexpression of Sema5B reduces the number of synaptic inputs Figure 4 (see previous page)
Overexpression of Sema5B reduces the number of synaptic inputs. (a-i) Confocal images of 13 days in vitro (DIV) hip-
pocampal cultures cotransfected at 10 DIV with postsynaptic density (PSD)-95-RFP plus green fluorescent protein (GFP) (a), 
GFP-Sema5B (d), or GFP-Δsema (g), and immunolabeled for synaptophysin (b, e, h). Although the number of PSD-95-red fluo-
rescent protein (RFP) puncta remained constant (c, f, i), there was a significant decrease in the number of synaptic inputs onto 
Sema5B overexpressing cells as measured by a decrease in the percentage of PSD-95 puncta that had an associated synapto-
physin puncta (j; Student's t test; P < 0.005). Similarly there was a correlative decrease in the density of synaptic inputs (j; Stu-
dent's t test; P < 0.05). The number and density of synaptic inputs onto cells overexpressing Sema5BΔsema was not significantly 
different than control (j; Student's t test; P > 0.5). The number of synapses being formed by Sema5B overexpressing cells, as 
measured by the number of PSD-95 puncta that colocalized with Syn-RFP (data not shown), was unchanged (k; Student's t test; 
P > 0.5). N = at least 15 neurons per condition from 3 separate cultures. Scale bar 20 μm.Neural Development 2009, 4:18 http://www.neuraldevelopment.com/content/4/1/18
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large tumor suppressor (DlgA), and zonula occludens-1
protein (zo-1))[25].
To further address the possibility that the observed
increase in synapse number and size may result from off-
target effects of the shRNAs, we determined whether this
phenotype could be rescued by overexpressing an shRNA-
resistant chick isoform of Sema5B in shRNA-expressing
neurons. Overexpression of chick Sema5B completely
abolished the shRNA-mediated increase in synapse
number and size (Figure 9e, f).
Discussion
Although individual synapses can be stable for prolonged
periods of time, synaptic connections also retain a
remarkable capacity to be rapidly disassembled and
reformed. The formation and elimination of synaptic con-
nections are particularly prominent during early develop-
ment, but continue in the adult, and are thought to be
essential for the cellular processes underlying learning
and memory [1,26]. Considerable efforts have focused on
the mechanisms underlying synaptogenesis; however, rel-
atively little is known about the molecular mechanisms
that control the elimination of synaptic contacts. The
speed at which synapse disassembly occurs has been
shown to be more rapid than the normal rates of protein
Schematic illustration of Sema5B function at synapses Figure 5
Schematic illustration of Sema5B function at synapses. Cells expressing high Sema5B levels exhibit fewer presynaptic 
inputs (b) compared to wild type cells (a). Consistent with these observations, a reduction in Sema5B levels results in a signif-
icant increase in the number of presynaptic inputs and the size of both pre and postsynaptic compartments (c). In contrast, the 
number of synapses made by cells expressing high levels of Sema5B (e) is similar to wild type cells (d).Neural Development 2009, 4:18 http://www.neuraldevelopment.com/content/4/1/18
Page 10 of 19
(page number not for citation purposes)
Figure 6 (see legend on next page)
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turnover at the synapse, indicating that synapse disassem-
bly is not only caused by the lack of maintenance of syn-
apses, but rather by mechanisms that actively drive
synapse breakdown. For example, the half-life of α-
amino-3-hydroxyl-5-methyl-4-isoxazole-propionate
(AMPA) receptors at a synapse has been measured to be
18 to 23 h [27] and yet live-imaging studies have demon-
strated that synapses containing AMPA receptors can be
eliminated in as quickly as 90 minutes [28].
Our data demonstrates an important role for Sema5B in
the elimination of synaptic connections. Overexpression
of full-length, wild type Sema5B in hippocampal neurons
resulted in a significant reduction in the number of syn-
apses. Surprisingly, the functional regulation appears to
be limited to the sema domain as synapse number
remained unaffected following overexpression of Sema5B
lacking this domain. Using time-lapse imaging of hippoc-
ampal neurons bathed in media containing secreted
Sema5B fragments, we determined that the decrease in the
number of synaptic inputs is not due to failure to form
synapses, but rather in a rapid elimination of synapses.
Together with the observation that knockdown of Sema5B
in cells increases the number and size of synapses, these
data demonstrate that Sema5B is expressed and secreted
by hippocampal neurons to regulate presynaptic input.
Proteolytic processing of Sema5B
A number of Sema5B N-terminal fragments between 110
and 30 kDa were detected by western blot analysis of cor-
tical and hippocampal tissue. Based on our observations
of Sema5B expression in other tissues and in heterologous
cell lines, full length Sema5B is approximately 150 kDa.
This would suggest that in the cortex and hippocampus,
Sema5B is cleaved extracellular to the transmembrane
domain, releasing an N-terminal protein that most often
contains the entire sema domain. This type of cleavage has
been observed in another transmembrane semaphorin,
Sema4D [22]. Sema4D can be cleaved at the plasma mem-
brane and released into the extracellular environment,
resulting in both a membrane-bound and a secreted mol-
ecule. A similar cleavage event may regulate Sema5B
release in hippocampal neurons, allowing the sema
domain to exert its effect in both a paracrine and auto-
crine manner. Whether Sema5B can function over longer
distances is unknown. Many semaphorins, including
Sema5A and B, exhibit complex interactions with the
extracellular matrix [19,29,30]. In particular, Sema5A and
B have been shown to bind to heparin and chondroitin
sulfate proteoglycans (CSPG) and in the case of Sema5A,
this binding regulates its function [19]. Similarly, the
punctate distribution of secreted semaphorins along the
cell surface and their interactions with their receptor neu-
oropilin-1 appears to be regulated by proteoglycan bind-
ing [29]. Whether similar interactions with the
extracellular matrix plays a role in localizing Sema5B to
hippocampal synapses is unknown.
Presently, little is known about the Sema5B receptor.
While plexin B3 has been shown to function as a receptor
for Sema5A in heterologous cells [31], an alternative,
unknown receptor appears to function in neurons [19].
Identifying the Sema5 receptor(s) is complicated by their
interactions with proteoglycans. For example, the binding
affinity of Sema5B to CSPG and heparin can be regulated
by the level and location of sulfation on the gly-
cosaminoglycan side chain, suggesting an additional level
of complexity in regulating Sema5B function [30]. Indeed,
Sema5A has been shown to have complete opposite func-
tions depending on whether it is bound by CSPG or
heparin [19]. This suggests the importance of the extracel-
lular matrix (ECM) molecules in potentially regulating
Sema5B interactions with its receptor.
Endogenous localization of Sema5B
While other semaphorins have been shown to effect syn-
apse function in vertebrate neurons [12,13,32,33], the
absence of specific antibodies has not allowed for an
examination of their distribution. Nonetheless, other
guidance molecules, such as the ephrins and their recep-
tors and repulsive guidance molecules (RGM), have been
shown to colocalize and function at the synapse [34-37].
Here we demonstrate that at least the N-terminal frag-
ments of Sema5B are localized predominantly in the cell
Hippocampal neurons respond to secreted Sema5B Figure 6 (see previous page)
Hippocampal neurons respond to secreted Sema5B. (a) Supernatant from human embryonic kidney (HEK)293 cells 
overexpressing hemaglutinin (HA)-Sema5BΔC was immunoprecipitated using an HA antibody, separated by SDS-PAGE, and 
immunoblots probed with anti-HA antibody. N = 4. (b) Hippocampal neurons (2 days in vitro (DIV)) were cocultured with 
HEK293 cells transfected with HA-Sema5BΔC and immunolabeled with anti-HA (red) and anti-neurofilament (green) antibod-
ies (anti-neurofilament antibodies also label HEK293 cells). Collapsed hippocampal growth cones (arrowheads) avoid HEK293 
cells overexpressing HA-Sema5BΔC (yellow). In contrast, neurites extend along non-transfected HEK293 cells (arrows). (c, d) 
Hippocampal neurons (1 DIV) treated with supernatant from HEK293 cells expressing HA-Sema5BΔC exhibit collapsed 
growth cones ((d), arrowhead) compared to cells treated with untransfected HEK293 cell supernatant, which had typical 
growth cones that extended numerous filopodia ((c), arrows). N > 6 assays. (e) An example of a single collapse bioactivity 
assay. Collapse activity was determined at least twice for each aliquot of Sema5B-containing supernatant. Scale bar 20 μm.Neural Development 2009, 4:18 http://www.neuraldevelopment.com/content/4/1/18
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There is a decrease in synapse number in cells treated with secreted Sema5B Figure 7
There is a decrease in synapse number in cells treated with secreted Sema5B. (a-i) Confocal images of 9 to 10 days 
in vitro (DIV) hippocampal neurons treated with supernatant from hemaglutinin (HA)-Sema5BΔC-expressing human embryonic 
kidney (HEK)293 cells and immunolabeled with anti-postsynaptic density (PSD)-95 (a-c) and anti-synaptophysin (d-f) antibodies. 
Effective concentrations were determined by growth cone collapse assays on 1 DIV hippocampal neurons, and reflect concen-
trations that confer 25% or 50% of maximum growth cone collapse. (g-j) Synapse number was determined by the number of 
synaptophysin puncta that colocalized with PSD-95. N = 25 neurons from 4 separate cultures. Scale bar 20 μm.Neural Development 2009, 4:18 http://www.neuraldevelopment.com/content/4/1/18
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Postsynaptic density (PSD)-95 puncta are eliminated upon treatment with secreted Sema5B Figure 8
Postsynaptic density (PSD)-95 puncta are eliminated upon treatment with secreted Sema5B. (a-f) Representa-
tive time-lapse confocal images of a 9 to 10 days in vitro (DIV) hippocampal neuron transfected with green fluorescent protein 
(GFP) (a, d) and PSD-95-red fluorescent protein (RFP) (b, e) and treated with secreted Sema5B (50% bioactivity). (c, f) Merged 
images of (a), (b) and (d), (e), respectively. There was a significant reduction of the number of PSD-95-RFP puncta while little 
change was observed in neurite morphology (compare (c') with (f')). (g) Bath application of secreted Sema5B for 1 h resulted 
in an elimination of approximately 50% of PSD-95-RFP puncta. N = 4 cells per condition. Scale bar 25 μm.Neural Development 2009, 4:18 http://www.neuraldevelopment.com/content/4/1/18
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Figure 9 (see legend on next page)
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body and along dendrites and axons, with modest accu-
mulation observed at synaptic sites. It is possible that
Sema5B is proteolytically processed within the cell and
the sema domain-containing fragment secreted or that
Sema5B is cleaved by extracellular proteases following
membrane insertion of the secretory vesicle. It would be
of interest to determine how this proteolytic process is
regulated and whether this process is modulated in active
versus inactive synapses as well as in mature versus devel-
oping circuits. It has yet to be definitively demonstrated
whether Sema5B is being released by presynaptic or post-
synaptic cells; however, our data suggest that Sema5B is
being released postsynaptically to regulate presynaptic
inputs (discussed below). Our observations suggest that it
is the local release of the N-terminal fragment that is
important for Sema5B regulation of synapse integrity,
however we cannot rule out a function for the C-terminal
fragment. Indeed, thrombospondins have previously
been shown to play a role in enhancing synaptogenesis
[18] and the C-terminal fragment of Sema5B consists of a
number of thrombospondin repeats. Nonetheless, we
could find no effect on synapse number or size when we
overexpressed a C-terminal fragment that was lacking the
sema domain.
The role of Sema5B in synapse disassembly
Overexpression of GFP-Sema5B resulted in a significant
decrease in the number of synaptic inputs being formed
on these cells. This was determined by cotransfecting cells
with PSD-95-RFP to identify postsynaptic compartments
in Sema5B-overexpressing cells and then immunostaining
for the presynaptic marker, synaptophysin. Interestingly,
when cells were cotransfected with Sema5B and synapto-
physin-RFP to label presynaptic compartments, and
immunolabeled with PSD-95 to identify synapses, no
change in synapse number was observed. Therefore, our
data support the conclusion that Sema5B fragments are
being secreted from postsynaptic cells to affect their pres-
ynaptic partners. Indeed, although the number of PSD-
95-RFP puncta is similar in control and Sema5B overex-
pressing cells, the proportion of synaptophysin associated
with these puncta is reduced. It is unlikely that Sema5B is
being secreted presynaptically as the number of synapses
being formed by the Sema5B overexpressing neuron onto
wild type cells remains constant. This is in accordance
with data from the cerebellum and the mammalian neu-
romuscular junction (NMJ) demonstrating that elimina-
tion is induced by the postsynaptic cell, and that
presynaptic disassembly precedes postsynaptic disassem-
bly [1,38]. Indeed, it has been proposed that in hippoc-
ampal neurons, Sema3A is released from postsynaptic
sites and binds to its receptor neuropilin 1 (NP-1) local-
ized to the presynaptic membrane, resulting in a signifi-
cant reduction in synapses. Although it was reported that
extracellular signal-regulated kinase (ERK) phosphoryla-
tion occurred in response to Sema3A, the signaling path-
way that resulted in synapse disassembly was not
identified [12].
If the cell is secreting increased Sema5B fragments, why
doesn't it impact the number of its synaptic outputs? Two
explanations are possible. First, it is possible that Sema5B
fragments do not diffuse freely, but remain local by its
association with ECM molecules to mediate its effects
locally. This would afford a higher degree of spatial reso-
lution for synapse elimination. Second, it is possible that
a sufficient concentration of freely diffusing Sema5B is
not reaching synapses being formed by axons and their
targets.
Overexpression of GFP-Sema5B resulted in a loss of pres-
ynaptic markers apposed to postsynaptic densities that
remain similar in number. In contrast, treatment of neu-
rons with supernatant from HEK293 cells resulted in the
rapid loss of postsynaptic markers. This discrepancy is
most likely due to the concentration of Sema5B fragments
bathing the cell. Moreover, this may reflect the temporal
nature of presynaptic and postsynaptic disassembly.
Sema5B knockdown increases synapse number and size Figure 9 (see previous page)
Sema5B knockdown increases synapse number and size. (a-d) Confocal images of 9 to 10 days in vitro (DIV) hippoc-
ampal neurons expressing postsynaptic density (PSD)-95-red fluorescent protein (RFP) plus either green fluorescent protein 
(GFP) (a) or GFP-short hairpin RNA (shRNA) (b). Cells were immunolabeled with anti-synaptophysin and synapse number 
determined by the percentage of PSD-95-RFP puncta that had an associated synaptophysin cluster (c-e). Similar to our previous 
observations, coexpression of a chick Sema5B with a scrambled shRNA resulted in a significant decrease in synapse number 
(compare (e) to Figure 4j; Student's t test, P < 0.001). In contrast, knockdown of Sema5B resulted in a significant increase in 
synapse number ((e); Student's t test shRNA1 and 3, P < 0.005). The increase in synapse number with Sema5B shRNA was 
abrogated by coexpression with an shRNA-insensitive chick Sema5B (e). In addition to an increase in synapse number, there 
was a twofold increase in the size of PSD-95-RFP puncta in Sema5B knockdown cells (Student's t test shRNA1 and 3, P < 
0.001) that was rescued by coexpression of a chick Sema5B ((f); Student's t test, P = 0.462 compared to control). A similar 
increase in the size of synaptophysin puncta associated with Sema5B knockdown was observed ((g); Student's t test shRNA1 
and 3, P < 0.005). N = at least 25 cells per condition from at least 3 separate cultures. Scale bar 10 μm.Neural Development 2009, 4:18 http://www.neuraldevelopment.com/content/4/1/18
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Sema5B signaling and synapse elimination
The actin cytoskeleton is known to play a key role in the
development and maintenance of young synapses. Presy-
naptically, treatment of neurons with latrunculin A results
in a reduction in the number and size of synaptophysin-
labeled clusters [39]. At the postsynaptic compartment,
actin depolymerization has been reported to elicit the
internalization [40] and diffusion [41] of neurotransmit-
ter receptors away from the synapse. Moreover, actin reg-
ulates the morphology and plasticity of dendritic spines,
the postsynaptic compartment for the majority of excita-
tory synapses. Interestingly, long-term depression induces
a shift in the spine F-actin/G-actin ratio to G-actin, and a
concomitant decrease in spine head volume with the
occasional disappearance of some spines [42]. The actin
cytoskeleton may therefore be a principal target for stabi-
lizing or destabilizing signals that ultimately result in syn-
apse maintenance or elimination.
Although little is known about the receptor(s) involved in
transducing Sema5B function, Sema5B has recently been
shown to stimulate growth cone collapse by inducing the
disassembly of adhesion complexes and the actin mesh-
work in growth cones [23]. This disassembly has been
shown to be due to the concurrent activation of calpain
and calcineurin [23], and it is possible that similar path-
ways may be activated during synapse disassembly. The
protease calpain is particularly intriguing as its activity
appears to function in regulating synaptic efficacy and
structure [43-45]. Moreover, a number of synaptic struc-
tural and signaling proteins are known substrates for cal-
pain, including PSD-95, β-catenin and the actin
nucleating proteins cortactin and Wiskott-Aldrich syn-
drome protein (WASP) [43,46-49], suggesting a direct
possible mechanism for Sema5B regulation of synapse
structure. Whether similar pathways observed during
growth cone collapse are stimulated during synapse
remodeling have not been tested.
Materials and methods
Antibody generation
Antibodies were generated against the N-terminus (amino
acids 20 to 131) of Sema5B. Homology comparisons
showed the least amount of conservation between sema-
phorins along this peptide length. Recombinant peptide
was produced using the glutathione-S-transferase (GST)
fusion system (Amersham Pharmacia Biotech, Baie
d'Urfe, QC, Canada)) and was purified with a glutathione
agarose affinity column (Sigma, Oakville, ON, Canada).
Female New Zealand white rabbits were immunized for
antibody generation. For the first injection, 0.5 ml of 1
mg/ml recombinant peptide was mixed with 0.5 ml Fre-
und's complete adjuvant. For boosters, 0.1 mg of recom-
binant peptide in 0.5 ml was mixed with 0.5 ml of
incomplete Freund's adjuvant. Adjuvant and protein were
emulsified before injection. Booster injections were given
every 2 weeks and antibody generation was monitored
with test bleeds and western blot analysis against the
fusion peptide. Typically, terminal bleeds were collected
after three boosters. The polyclonal antibodies were
immunoaffinity purified with AminoLink columns
(Fisher, Nepean, ON, Canada).
Recombinant DNA
Full-length Sema5B was inserted into pEGFP-C1
(Clonetech, Mountain View, CA, USA) at the HindIII and
SacII sites. Sema5BΔsema (lacking amino acids 1 to 551)
was generated using standard PCR and similarly sub-
cloned into pEGFP-C1. Full-length chick Sema5B and
Sema5BΔC (lacking amino acids 1,001 to 1,093) were
subcloned into the XmaI/SacII sites of the HA epitope
tagged pDisplay expression vector (Invitrogen, Burlington
ON, Canada) to express an N-terminal tagged HA fusion
protein. Multiple stop codons were positioned before the
platelet derived growth factor receptor (PDGFR) trans-
membrane region of the vector. The PSD-95-RFP and syn-
aptophysin-RFP constructs were kind gifts from D Bredt
(Eli Lilly & Co., Indianapolis, IN, USA) and L Reichardt
(Dept. Physiology, UCSF, CA, USA), respectively. Genera-
tion of shRNA vectors was performed as described previ-
ously [17]. The following sequences were targeted:
shRNA1 (561) = 5'-GGACTATTGAGAAGATC AA and
shRNA3 (1,664) = 5'-GAAGACAGTT CCAACATGA. One
targeted sequence generated an incorrect final insert
sequence with no homology to Sema5B and was therefore
used as a scrambled control. Oligoduplex palindromes
were cloned into the XhoI/HpaI restriction sites of pLenti-
lox 3.7, which contains an internal ribosomal entry site
(IRES) GFP sequence downstream of the cloning site.
Resultant shRNA vectors were tested for their ability to
knock down Sema5B expression by immunocytochemis-
try of transfected hippocampal cells.
Neuronal cultures
Rat hippocampi from E18 fetal rats were prepared as pre-
viously described [50] and plated at a density of 130 cells/
mm2. Neurons were transfected using lipofectamine 2000
at 7 to 8 DIV as per the manufacturer's recommendation.
All transfected cells were fixed and analyzed 2 to 3 days
after transfection. For HEK cell/hippocampal neuron coc-
ultures, wild type HEK cells or cells expressing GFP-
Sema5B were plated at approximately 50 cells/mm2. At 24
h later, freshly dissociated hippocampal neurons were
overlaid onto dishes at a density of 130 cells/mm2.
Immunohistochemistry
Brain sections
Adult male and P1 mice (P30-P60) were anesthetized and
perfused with phosphate-buffered saline (PBS) (pH 7.4),
followed by 4% paraformaldehyde (PFA) in PBS. TheNeural Development 2009, 4:18 http://www.neuraldevelopment.com/content/4/1/18
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brains were dissected out and post-fixed in 4% PFA for 2
h before going through a series of sucrose-PBS solutions
(10% to 30%). Whole brains were embedded in TissueTek
(Sakura Finetek, Torrance, CA, USA) and frozen in liquid
nitrogen. The tissue was cut into 12 μm thick coronal sec-
tions using an HM 500 cryostat (Microm Instruments, San
Marcos, CA, USA). Vectastain immunocytochemistry was
performed as described previously [51] Briefly, sections
were permeabilized in 0.1% Triton-X for 30 minutes and
blocked in 4% goat serum for 20 minutes before incuba-
tion with anti-5B overnight at 4°C. For preadsorption
experiments, Sema5B N-terminal peptide (amino acids 20
to 131) was added in excess (1 to 3 times the concentra-
tion of anti-5B antibody) to an aliquot of anti-5B and
allowed to mix for 1 h before applying to tissue. After
overnight incubation a sections were washed and then
incubated with goat anti-rabbit biotin-conjugated second-
ary antibody (1:200, Vector Laboratories, Burlingame, CA,
USA) for 1 h at room temperature. Labeling was visualized
using the Vectastain ABC peroxidase and Vector VIP kits
(Vector Laboratories) as per the manufacturer's recom-
mendation. For fluorescent immunocytochemistry sec-
tions were incubated with a polyclonal goat anti-rabbit
Alexa Fluor 488-conjugated secondary antibody (1:500;
Molecular Probes, Eugene, OR, USA). Sections were then
dehydrated and mounted in Permount (Fisher).
Hippocampal neuron cultures
Neuron cultures were fixed in 4% paraformaldehyde/4%
sucrose for 10 minutes, permeabilized in 0.1% Triton-X
for 10 minutes, and then blocked in 10% goat serum for
1 hr at room temperature. Primary antibodies were
applied in 1% goat serum overnight at 4°C and secondary
antibodies were applied in 1% goat serum for 1 hr at room
temperature. Primary antibodies were mouse anti-synap-
tophysin (Sigma) and mouse anti-PSD-95 (ABR, Golden,
Co, USA). Secondary antibodies were Alexa Fluor 488,
Alexa Fluor 633, and Texas Red-conjugated goat anti-
mouse or goat anti-rabbit antibodies (Molecular Probes).
Sema5B bath application
For collapse assays, supernatant was collected from wild
type HEK293 cells, or cells expressing HA-Sema5B, GFP-
Sema5B, or a recombinant Sema5B that had a C-terminal
deletion of 100 amino acids (HA-Sema5BΔC). For syn-
apse elimination assays, supernatant was collected from
wild type HEK293 cells or cells expressing HA-Sema5BΔC.
The advantage of using the HA-Sema5BΔC was that a sig-
nificantly greater amount of proteolytically cleaved
Sema5B (containing the sema domain) was released into
the media. Supernatants were concentrated 100 times by
Centricon concentrators (Millipore, Billerica, MA, USA)
with 30 kDa cut-offs. Bioactivity of the concentrated
supernatant was determined by measuring growth cone
collapse 1 h after addition to 1 DIV hippocampal neurons
as described previously [52]. Briefly, growth cones lacking
lamellipodia and extending four or less filopodia were
considered collapsed. For each batch of supernatant,
experiments were performed twice with at least 20 ran-
domly selected growth cones scored per experiment. Con-
centrated supernatant that stimulated 50% and 25%
growth cone collapse was used for bath application of hip-
pocampal cultures.
Image analysis and quantification
Transfected hippocampal neurons and fluorescent immu-
nocytochemical brain sections were imaged using an
Olympus Fluoview 1000 confocal microscope (60 ×/1.4
Oil Plan-Apochromat; Olympus, Markham, ON, Can-
ada). All images in a given experiment were captured with
the same exposure time and conditions. Brightfield
vectastain immunocytochemical images were captured
using an Axioplan 2 Imaging microscope (Zeiss, Jena, Ger-
many) equipped with a Retiga 1350X camera (Quantita-
tive Imaging Corporation, Burnaby, British Columbia,
Canada) and Northern Eclipse software (Empix Imaging,
Mississauga, Ontario, Canada).
Quantification of puncta colocalization
Images of cells immunolabeled for Sema5B, synapto-
physin, or PSD-95 were analyzed using ImageJ with a
colocalization plug-in downloaded from the program's
website [53]. Following thresholding, points of colocali-
zation were defined as regions greater than 4 pixels in size
where the intensity ratio of the two channels was greater
than 50%. Numbers of colocalized puncta were expressed
as a percentage of the total number of puncta, quantified
using the same threshold and size criteria and excluding
colocalized points that appeared to be within the cell
body. The average numbers of colocalized synaptic puncta
in each treatment group were analyzed for statistical sig-
nificance using the Student's t test.
Quantification of PSD-95-GFP puncta following Sema5B bath 
treatment
Neurons expressing PSD-95-GFP were bathed in superna-
tant from wild type HEK293 cells, or cells expressing HA-
Sema5BΔC. For each experiment the concentrated super-
natant was diluted in 100 μl culture media just prior to
addition to the cells. Cells were imaged every 10 minutes
for 60 to 90 minutes immediately following sema bath
application. Images were imported into Image J where
they were thresholded and analyzed.
Immunoblot analysis
Hippocampal and cortical tissues, as well as cultured hip-
pocampal neurons were lysed in approximately 4 vol-
umes (w/v) of buffer containing (50 mM Tris pH 7.4, 150
mM NaCl, 1.0% NP-40, 10% glycerol). Extracts were run
using standard SDS-PAGE, and immunoblots probedNeural Development 2009, 4:18 http://www.neuraldevelopment.com/content/4/1/18
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with anti-Sema5B. Proteins were visualized using
enhanced chemiluminence on a Bio-Rad Versadoc 4000.
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